AnalystsKemp DolliverKemp Dolliver's Stock Forecasts
AnalystsKemp Dolliver
Analyst Ranking
Bottom 7%
#4659 out of 4986 analysts
Average Return
-27.78%
Win Rate
21%3 out of 14
Risk vs Reward
Poor
Good
Kemp Dolliver's 5 best and worst ratings
Kemp Dolliver Analyst Color
Get additional color on Kemp Dolliver's coverage of popular stocks
Kemp Dolliver's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Radiopharm Theranostics LtdRADX | 1 | Strong Buy | $18.00 | +258.57% | Initiates Coverage On | a month ago |
Lisata Therapeutics IncLSTA | 1 | Strong Buy | $32.00 | +1,180.00% | Maintains | a month ago |
Y Mabs Therapeutics IncYMAB | 1 | Strong Buy | $17.00 | +99.53% | Initiates Coverage On | 9 months ago |
Ibio IncIBIO | 1 | Strong Buy | $3.60 | N/A | Initiates Coverage On | a year ago |
Dare Bioscience IncDARE | 1 | Strong Buy | $36.00 | N/A | Upgrades | a year ago |
Outlook Therapeutics IncOTLK | 1 | Strong Buy | $31.40 | N/A | Upgrades | 2 years ago |
Point Biopharma Global IncPNT | 1 | Hold | $12.50 | N/A | Downgrades | 2 years ago |
Oncternal Therapeutics IncONCT | 1 | Strong Buy | $40.00 | N/A | Upgrades | 2 years ago |
Lantheus Holdings IncLNTH | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 2 years ago |
Hyperion Defi IncHYPD | 1 | Strong Buy | $640.00 | N/A | Initiates Coverage On | 2 years ago |
Procaps Group SaPROCF | 1 | Hold | $4.50 | N/A | Downgrades | 2 years ago |
Genelux CorpGNLX | 1 | Hold | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Electrocore IncECOR | 1 | Strong Buy | $18.75 | N/A | Initiates Coverage On | 3 years ago |
Edesa Biotech IncEDSA | 1 | Strong Buy | $13.00 | N/A | Maintains | 3 years ago |
Scynexis IncSCYX | 1 | Strong Buy | $8.00 | N/A | Assumes | 3 years ago |
Verrica Pharmaceuticals IncVRCA | 1 | Strong Buy | $200.00 | N/A | Initiates Coverage On | 3 years ago |
Icecure Medical LtdICCM | 1 | Strong Buy | $5.65 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.